klinische pädiatrie
130330
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Klinische Pädiatrie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Board
Table of Contents
German National License
Imprint
Media
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Job Board
Job Opportunities
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Issues
Current Issue
Free Sample Issue (01/2024)
Related Books
Pädiatrie
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
X
Y
Z
Ecker, J
Functional analysis of class I HDAC inhibition in group 3 medulloblastoma to identify synergistic drug combinations
Ehlert, K
Low regulatory T-cells are associated with improved survival of neuroblastoma patients treated with anti-GD2 antibodies
Eiblwieser, J
Multiplex Droplet Digital PCR-based Targeted Enrichment NGS for identification of tumor markers in Ewing Sarcoma (EwS)
Elder, A
Splicing factors of the SF3b complex PHF5A and SF3B1 regulate the DNA damage response in ALL
Emmrich, E
Cooperativity between miR-125b and Gata1 s in the pathogenesis of Down syndrome-associated myeloid leukemia
Enshaei, A
Dasatinib and Dexamethasone offer a novel therapeutic strategy for T-cell Acute Lymphoblastic Leukaemia
Erlacher, M
Analyzing the therapeutic efficacy of navitoclax and MCL-1 inhibitors in juvenile myelomonyctic leukemia
Too little is too much: Leukemogenesis in the Gata2 syndrome
Mutational and transcriptomic landscapes in hematopoietic cells of Fanconi anemia patients
Analyzing the effects of oncogenic SHP2 on apoptosis signaling during malignant transformation